跳至主要内容
临床试验/CTRI/2024/02/063141
CTRI/2024/02/063141招募中4 期

Comparative Evaluation of Three Vitamin D3 Formulations for Sequential Improvement of Vitamin D3 Levels throughout a period of 3-Months. - NI

Dr Roshan Pawar0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Willing to provide voluntary written informed consent.
  • 2.If an individual is unable to provide informed consent due to reasons such as illiteracy, a Legal Authorized Representative (LAR) will be required to provide written informed consent.
  • 3.Male or Female subjects between 18 to 65 years of age (both inclusive)
  • 4.Vitamin D3 deficiency less than 20 ng/ml
  • 5.Willing and able to comply with the protocol.

排除标准

  • 1.Any Surgery or hospitalization within 28 days before enrolment
  • 2.Known hypersensitivity to any component of the investigational product and other medications used in this study
  • 3.Patients already on supplementation of calcium and/or Vitamin D
  • 4.Patients suffering from acute or chronic infection(s)
  • 5.BMI greater than 40 Kg/m2
  • 6.Female patients who are pregnant or nursing
  • 7.Patients with H/O concurrent disease or conditions like ESRD, pre-existing liver cell failure, terminally ill cancer or critically ill patients, which in the opinion of the investigator does not allow participation of the patient in this study
  • 8.Has participated in any other clinical trial and received experimental medications within 4 weeks prior to screening

研究者

发起方
Dr Roshan Pawar

相似试验